nodes	percent_of_prediction	percent_of_DWPC	metapath
Metixene—HTR2C—type 2 diabetes mellitus	0.772	1	CbGaD
Metixene—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0571	1	CbGbCtD
Metixene—Promethazine—CALM1—type 2 diabetes mellitus	0.000627	0.0753	CrCbGaD
Metixene—Maprotiline—HTR2C—type 2 diabetes mellitus	0.00048	0.0576	CrCbGaD
Metixene—Mirtazapine—ADRA2A—type 2 diabetes mellitus	0.000476	0.0572	CrCbGaD
Metixene—Mirtazapine—HTR2C—type 2 diabetes mellitus	0.000439	0.0527	CrCbGaD
Metixene—Cyproheptadine—HTR2C—type 2 diabetes mellitus	0.000425	0.0511	CrCbGaD
Metixene—Mesoridazine—HTR2C—type 2 diabetes mellitus	0.000368	0.0442	CrCbGaD
Metixene—Maprotiline—CYP1A2—type 2 diabetes mellitus	0.000362	0.0435	CrCbGaD
Metixene—Prochlorperazine—HTR2C—type 2 diabetes mellitus	0.000356	0.0428	CrCbGaD
Metixene—Mianserin—ADRA2A—type 2 diabetes mellitus	0.00035	0.042	CrCbGaD
Metixene—Mirtazapine—CYP1A2—type 2 diabetes mellitus	0.000331	0.0397	CrCbGaD
Metixene—Mianserin—HTR2C—type 2 diabetes mellitus	0.000322	0.0387	CrCbGaD
Metixene—Alimemazine—CYP3A4—type 2 diabetes mellitus	0.000304	0.0365	CrCbGaD
Metixene—Thioridazine—ADRA2A—type 2 diabetes mellitus	0.000302	0.0362	CrCbGaD
Metixene—Thioridazine—HTR2C—type 2 diabetes mellitus	0.000278	0.0333	CrCbGaD
Metixene—Quetiapine—ADRA2A—type 2 diabetes mellitus	0.000271	0.0326	CrCbGaD
Metixene—Mequitazine—CYP3A4—type 2 diabetes mellitus	0.000262	0.0315	CrCbGaD
Metixene—Quetiapine—HTR2C—type 2 diabetes mellitus	0.00025	0.03	CrCbGaD
Metixene—Promazine—ADRA2A—type 2 diabetes mellitus	0.00025	0.03	CrCbGaD
Metixene—Mianserin—CYP1A2—type 2 diabetes mellitus	0.000243	0.0292	CrCbGaD
Metixene—Promazine—HTR2C—type 2 diabetes mellitus	0.00023	0.0276	CrCbGaD
Metixene—Thioridazine—CYP2E1—type 2 diabetes mellitus	0.00022	0.0265	CrCbGaD
Metixene—Mirtazapine—CYP3A4—type 2 diabetes mellitus	0.000219	0.0263	CrCbGaD
Metixene—Thioridazine—CYP1A2—type 2 diabetes mellitus	0.00021	0.0252	CrCbGaD
Metixene—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	0.000178	0.0214	CrCbGaD
Metixene—Promazine—CYP1A2—type 2 diabetes mellitus	0.000173	0.0208	CrCbGaD
Metixene—Mianserin—CYP3A4—type 2 diabetes mellitus	0.000161	0.0193	CrCbGaD
Metixene—Quetiapine—CYP3A4—type 2 diabetes mellitus	0.000125	0.015	CrCbGaD
Metixene—Promazine—CYP3A4—type 2 diabetes mellitus	0.000115	0.0138	CrCbGaD
Metixene—HTR2C—Signaling Pathways—APOB—type 2 diabetes mellitus	1.97e-05	0.000121	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.96e-05	0.000121	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.94e-05	0.000119	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.94e-05	0.000119	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.94e-05	0.000119	CbGpPWpGaD
Metixene—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	1.94e-05	0.000119	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—APOE—type 2 diabetes mellitus	1.93e-05	0.000119	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—LEP—type 2 diabetes mellitus	1.93e-05	0.000119	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.93e-05	0.000119	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.91e-05	0.000118	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.91e-05	0.000118	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.9e-05	0.000117	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.9e-05	0.000117	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.9e-05	0.000117	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.9e-05	0.000117	CbGpPWpGaD
Metixene—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	1.89e-05	0.000117	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.89e-05	0.000117	CbGpPWpGaD
Metixene—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	1.89e-05	0.000116	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—LPL—type 2 diabetes mellitus	1.88e-05	0.000116	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.88e-05	0.000116	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.88e-05	0.000116	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.84e-05	0.000113	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	1.84e-05	0.000113	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.82e-05	0.000112	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	1.82e-05	0.000112	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.8e-05	0.000111	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.8e-05	0.000111	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.79e-05	0.000111	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.78e-05	0.00011	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.78e-05	0.000109	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.78e-05	0.000109	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.76e-05	0.000109	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.76e-05	0.000108	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.76e-05	0.000108	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.76e-05	0.000108	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	1.75e-05	0.000108	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.75e-05	0.000108	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.75e-05	0.000108	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.75e-05	0.000108	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.74e-05	0.000107	CbGpPWpGaD
Metixene—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	1.74e-05	0.000107	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.74e-05	0.000107	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.74e-05	0.000107	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.74e-05	0.000107	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.73e-05	0.000107	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.73e-05	0.000106	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.73e-05	0.000106	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—INS—type 2 diabetes mellitus	1.72e-05	0.000106	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.72e-05	0.000106	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.72e-05	0.000106	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.72e-05	0.000106	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	1.71e-05	0.000105	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.7e-05	0.000105	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.7e-05	0.000105	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.7e-05	0.000104	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	1.7e-05	0.000104	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.69e-05	0.000104	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—C3—type 2 diabetes mellitus	1.69e-05	0.000104	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.69e-05	0.000104	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.68e-05	0.000103	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.67e-05	0.000103	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.67e-05	0.000103	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.67e-05	0.000103	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.67e-05	0.000103	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.67e-05	0.000103	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.66e-05	0.000102	CbGpPWpGaD
Metixene—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	1.66e-05	0.000102	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.65e-05	0.000102	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—INS—type 2 diabetes mellitus	1.65e-05	0.000102	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	1.63e-05	0.0001	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.62e-05	0.0001	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.62e-05	0.0001	CbGpPWpGaD
Metixene—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	1.62e-05	9.99e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	1.62e-05	9.97e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.61e-05	9.94e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.61e-05	9.92e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—AGT—type 2 diabetes mellitus	1.61e-05	9.9e-05	CbGpPWpGaD
Metixene—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	1.6e-05	9.88e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.6e-05	9.87e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.6e-05	9.84e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.6e-05	9.83e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.59e-05	9.79e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.59e-05	9.79e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.58e-05	9.76e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.58e-05	9.76e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.58e-05	9.74e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—LEP—type 2 diabetes mellitus	1.58e-05	9.71e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—APOE—type 2 diabetes mellitus	1.58e-05	9.71e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.57e-05	9.66e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.56e-05	9.59e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.52e-05	9.38e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.52e-05	9.35e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.52e-05	9.34e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.51e-05	9.31e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.51e-05	9.31e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.5e-05	9.26e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.5e-05	9.21e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.49e-05	9.18e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.49e-05	9.15e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.48e-05	9.1e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	1.46e-05	9e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	1.46e-05	8.98e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.45e-05	8.92e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.45e-05	8.92e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	1.44e-05	8.89e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—RELA—type 2 diabetes mellitus	1.42e-05	8.77e-05	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	1.41e-05	8.7e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.41e-05	8.66e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.39e-05	8.59e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.39e-05	8.57e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.39e-05	8.56e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.39e-05	8.56e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.39e-05	8.54e-05	CbGpPWpGaD
Metixene—CHRM3—Metabolism—INS—type 2 diabetes mellitus	1.39e-05	8.54e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	1.38e-05	8.53e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.38e-05	8.48e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.37e-05	8.46e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.37e-05	8.45e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.37e-05	8.41e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—RELA—type 2 diabetes mellitus	1.36e-05	8.4e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.36e-05	8.39e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.36e-05	8.38e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.36e-05	8.38e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	1.36e-05	8.36e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	1.36e-05	8.36e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.35e-05	8.3e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—INS—type 2 diabetes mellitus	1.35e-05	8.29e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.35e-05	8.29e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.34e-05	8.27e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.34e-05	8.27e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.34e-05	8.26e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.33e-05	8.18e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.32e-05	8.16e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.3e-05	8.02e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.3e-05	8.01e-05	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.3e-05	7.98e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.3e-05	7.98e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.28e-05	7.91e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.28e-05	7.91e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.28e-05	7.88e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.28e-05	7.86e-05	CbGpPWpGaD
Metixene—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	1.27e-05	7.83e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.27e-05	7.8e-05	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.24e-05	7.64e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.24e-05	7.62e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.23e-05	7.57e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.22e-05	7.52e-05	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	1.22e-05	7.49e-05	CbGpPWpGaD
Metixene—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	1.22e-05	7.49e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.21e-05	7.48e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.21e-05	7.47e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.21e-05	7.45e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.2e-05	7.39e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.2e-05	7.38e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.18e-05	7.27e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.18e-05	7.27e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.18e-05	7.25e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	1.16e-05	7.16e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.16e-05	7.16e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	1.16e-05	7.14e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.15e-05	7.08e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	1.15e-05	7.07e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.14e-05	7.05e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.14e-05	7.02e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.13e-05	6.96e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.13e-05	6.94e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.12e-05	6.93e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.12e-05	6.92e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.12e-05	6.9e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.12e-05	6.9e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.12e-05	6.89e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—SRC—type 2 diabetes mellitus	1.12e-05	6.89e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.12e-05	6.87e-05	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	1.11e-05	6.85e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.11e-05	6.84e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.11e-05	6.84e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.11e-05	6.83e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.1e-05	6.8e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.09e-05	6.71e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—SRC—type 2 diabetes mellitus	1.07e-05	6.6e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.07e-05	6.58e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.06e-05	6.56e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.05e-05	6.49e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.04e-05	6.43e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.02e-05	6.28e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.02e-05	6.28e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.02e-05	6.26e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.02e-05	6.26e-05	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.01e-05	6.23e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.01e-05	6.2e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.01e-05	6.2e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1e-05	6.17e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1e-05	6.16e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.96e-06	6.13e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.8e-06	6.04e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	9.6e-06	5.91e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.58e-06	5.9e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	9.57e-06	5.89e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	9.47e-06	5.84e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.47e-06	5.83e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.39e-06	5.78e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.37e-06	5.77e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.19e-06	5.66e-05	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.74e-06	5.38e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	8.73e-06	5.38e-05	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.71e-06	5.36e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.66e-06	5.33e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.63e-06	5.31e-05	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.62e-06	5.31e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.6e-06	5.3e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.57e-06	5.28e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.55e-06	5.26e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.5e-06	5.24e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.49e-06	5.23e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.18e-06	5.04e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.15e-06	5.02e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.09e-06	4.99e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.08e-06	4.97e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.07e-06	4.97e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.99e-06	4.92e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.93e-06	4.89e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.91e-06	4.87e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.83e-06	4.82e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.81e-06	4.81e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.65e-06	4.71e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.54e-06	4.65e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	7.53e-06	4.64e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	7.52e-06	4.63e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	7.45e-06	4.59e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.35e-06	4.52e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.32e-06	4.51e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.25e-06	4.47e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	7.22e-06	4.44e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.95e-06	4.28e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.74e-06	4.15e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.72e-06	4.14e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.66e-06	4.1e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.66e-06	4.1e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.61e-06	4.07e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.59e-06	4.06e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.53e-06	4.02e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	5.88e-06	3.62e-05	CbGpPWpGaD
Metixene—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	5.59e-06	3.44e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.43e-06	3.34e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.08e-06	3.13e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	5.06e-06	3.12e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.02e-06	3.09e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.69e-06	2.89e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.67e-06	2.88e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.63e-06	2.85e-05	CbGpPWpGaD
